GlassScriptPhysician profile
Yoslady Morales
NPI 1932608999
$1,750.94
in general payments reported to CMS, 2019-2025
23 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $704 · 2022: $155 · 2023: $214 · 2024: $425 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $455.54 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $293.57 | 2021-2022 | |
| Abbvie INC. | $279.00 | 2021-2025 | |
| Horizon Therapeutics Plc | $132.76 | 2021 | |
| W. L. Gore & Associates, INC. | $93.11 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Kerecis Limited | $75.28 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbott Laboratories | $74.13 | 2021-2025 | Freestyle Libre 3, Emboshield Nav6 |
| Tactile Systems Technology INC | $31.81 | 2024 | Flexitouch Plus, Entre Plus |
| Exact Sciences Corporation | $30.56 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $29.77 | 2021-2023 | Jardiance |
| Chiesi USA, INC. | $29.36 | 2025 | Filsuvez |
| Biohaven Pharmaceuticals, INC. | $28.41 | 2021 | |
| Convatec INC. | $27.51 | 2023 | |
| Merck Sharp & Dohme LLC | $25.43 | 2021-2022 | |
| Urgo Medical North America, LLC | $23.93 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $21.11 | 2021 | |
| Genentech USA, INC. | $16.64 | 2021 | |
| Shield Therapeutics INC | $15.25 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.00 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.96 | 2021 | |
| Becton, Dickinson and Company | $13.56 | 2021 | |
| La Jolla Pharmaceutical Company | $13.42 | 2024 | Xerava |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoslady Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.